α2-antiplasmin modulates bone formation by negatively regulating osteoblast differentiation and function

Area of Science:

• Biochemistry
• Cell Biology
• Bone Biology

Background:

• Alpha2-antiplasmin (α2AP) is a known plasmin inhibitor.
• α2AP also regulates extracellular matrix production, cell growth, and differentiation independently of its inhibitory function.
• The role of α2AP in bone metabolism remains largely unexplored.

Purpose of the Study:

• To investigate the role of α2AP in bone formation.
• To elucidate the molecular mechanisms by which α2AP influences osteoblast differentiation and function.

Main Methods:

• Calcein incorporation assays in α2AP-deficient mice to assess bone formation rates.
• Measurement of osteocalcin expression and alkaline phosphatase activity in femurs and serum.
• In vitro studies on primary calvarial osteoblasts (OBs) and MC3T3-E1 cells to evaluate OB differentiation.
• Analysis of Wnt/β-catenin pathway activation, including β-catenin expression and low-density lipoprotein receptor-related protein 6 (LRP6) activation.

Main Results:

• α2AP deficiency significantly enhanced the bone formation rate in mice.
• Osteocalcin levels and alkaline phosphatase activity were elevated in α2AP-deficient mice.
• α2AP deficiency promoted osteoblast differentiation in primary cells but attenuated it in MC3T3-E1 cells.
• α2AP was found to inhibit Wnt-3a-induced β-catenin expression and LRP6 activation in MC3T3-E1 cells, indicating negative regulation of the Wnt/β-catenin pathway.

Conclusions:

• α2AP negatively regulates osteoblast differentiation and function.
• The inhibitory effect of α2AP on bone formation is mediated through the suppression of the Wnt/β-catenin signaling pathway.
• These findings suggest that targeting α2AP could be a potential therapeutic strategy for managing bone disorders.